Avocats – United States
Parcourez les avocats référencés pour United States. Consultez chaque profil pour connaître les domaines d’expertise, les inscriptions au barreau, les langues et les coordonnées, puis prenez contact directement.
12 723 avocats référencés
Christopher Giancarlo
Please see https://www.willkie.com/professionals/g/giancarlo%20j%20christopher
Willkie Farr & Gallagher LLP
Christopher Giordano
Partner; Chair of DLA Piper's New York Corporate Group; Chair of DLA Piper's US Mergers and Acquisitions Group
DLA Piper LLP (US)
Christopher Girouard
Partner - Corporate and Finance Transactions
Bryan Cave Leighton Paisner
Christopher Gladbach
Partner Christopher Gladbach counsels clients in energy M&A, project development, tax equity and project finance transactions. Chris works with energy clients in structuring complex equity and debt investments, advises both buyers and sellers in the power sector in mergers and acquisitions, and joint ventures, and on the development of large-scale energy projects. He assists his clients in mitigating and allocating risk associated with these transactions in conjunction with achieving their primary business and financial objectives. Chris has extensive experience advising clients pursuing opportunities involving the development and financing of United States Department of Defense (DoD) energy projects. He counsels developers, purchasers, lenders and tax equity investors in government contracts and structuring project development and financing arrangements to account for unique risks. In addition, Chris represents market-leading private equity funds and institutional investors in power asset transactions, and understands the unique challenges and opportunities that these clients face. Please visit our website for further details: https://www.mwe.com/people/gladbach-christopher/
McDermott Will & Schulte
Christopher Gonnella
Click here for attorney bio.
Paul, Weiss, Rifkind, Wharton & Garrison LLP
Christopher Greco
Chris Greco is a partner in the Restructuring Practice Group and is global co-chair of Kirkland’s Firmwide Recruiting Committee. He represents companies, sponsors and investors in complex liability management, financings, recapitalizations, restructurings and other special situation transactions. For nearly two decades, Chris has advised clients on some of the largest stressed and distressed situations in the energy, retail, healthcare, entertainment, media, education, technology, transportation, and global engineering and construction industries. In recent years, Chris has advised clients in some of the most complex and novel liability management exercises (LME) ever completed, including LMEs for Travelport, MultiPlan, Packer’s Sanitation, among many others. Chris has led dozens of successful out-of-court restructurings, avoiding the need for a formal court proceeding where possible, including matters such as Wheels Up, Casper Sleep, Wahoo Fitness, Dunn Paper, Service King, Team INC and PSS Industrial, as well as a significant number of other confidential engagements.
Kirkland & Ellis LLP
Christopher Grobbel
Counsel
Goodwin
Christopher H. Schott
Christopher Schott primarily advises on price reporting and other compliance obligations related to the Medicaid, Medicare, and 340B drug pricing programs. He combines extensive regulatory insight with deep industry knowledge to support pharmaceutical clients at all stages of the product life cycle. Market entrants and investors also seek Christopher’s advice when evaluating potential opportunities and strategies. Methodologies and reasonable assumptions that support the periodic certification and submission of price reporting metrics are at the heart of compliance with the federal programs, and Christopher frequently advises clients in connection with reporting Average Manufacturer Price and Best Price under the Medicaid Drug Rebate Program, Average Sales Price under Medicare Part B, and the 340B ceiling price. The definitions of the price types and how the federal programs use the data are relevant to many different facets of the pharmaceutical business, which is why Christopher bases his counsel on a full consideration of the client’s product portfolio, distribution model, and strategic goals. The drug pricing policy landscape is ever evolving, and Christopher assists clients through policy advocacy, such as by evaluating legislative and policy proposals, drafting white papers, and meeting with stakeholders. Christopher also helps pharmaceutical manufacturers proactively engage with federal regulators through in-person advocacy and comment drafting. Additionally, he frequently advises drug manufacturers seeking guidance from regulators regarding specific issues or commercial proposals. Christopher draws on his regulatory knowledge and understanding of the pharmaceutical industry to support a range of corporate transactions, including acquisitions and divestitures, as well as licensing and co-promotion arrangements. He regularly helps clients evaluate the impact of price reporting requirements on proposed mergers and acquisitions, as well as to navigate due diligence matters and the post-closing transition of regulatory responsibilities.
Latham & Watkins
Christopher Halliday
Principal
Offit Kurman
Christopher Harbin
Senior Counsel
Platt Richmond
Christopher Harris
Litigation & Trial Partner
Latham & Watkins
Christopher Harrison
Partner, M&A
Sterlington PLLC
Christopher Hartmann
Chris has extensive experience representing clients in all aspects of complex commercial real estate transactions, including joint ventures, preferred equity investments, acquisitions, financings and sales.
Kirkland & Ellis LLP
Christopher Harvey
Partner
Dechert
Christopher Harwood
Christopher B. Harwood is a former federal prosecutor with many years of experience handling complex civil litigation, as well as criminal and regulatory matters. His extensive experience includes dozens of investigations, litigations, and settlements involving the False Claims Act, the Bank Secrecy Act, the Anti-Kickback Statute, and FIRREA. Chris’s cases have involved allegations of financial fraud, healthcare fraud, federal program and grant fraud, money laundering, failure to file SARs, failure to implement an effective anti-money laundering program, violation of U.S. sanctions laws, breach of contract, and employment discrimination and retaliation.
Morvillo Abramowitz Grand Iason & Anello P.C.
Christopher Hazlitt
Senior Counsel - Corporate and Finance Transactions
Bryan Cave Leighton Paisner
Christopher Hazuka
Dr. Christopher (Chris) Hazuka advises life sciences companies on the agreements and transactions that are essential to their success at all stages of their life cycle, drawing on his experience as a scientist and former in-house counsel. Chris, based in both San Diego and the Bay Area, brings clients a scientist’s sensibility, a passion for creating synergies to bring innovation to market, and a pragmatic understanding of the full complement of business and legal issues clients face. In particular, he helps established and emerging life sciences companies by providing problem-solving advice to structure, negotiate, and execute a myriad of transactions, such as: Complex collaborations Intellectual property and technology licenses Relationships to assist in developing drug candidates and innovative technologies Manufacturing and quality agreements Commercial agreements, including profit sharing and co-promotion agreements University licenses Clinical trial agreements In the context of strategic transactions, he advises on: Due diligence and disclosure matters Venture financings, public offerings, and M&A transactions Chris earned a PhD at Stanford University in the Neurosciences Program for his work in Dr. Richard Scheller’s laboratory on the molecular mechanisms of neurotransmission. He later served as in-house counsel for Orexigen Therapeutics, an emerging company that successfully developed and commercialized a drug to treat obesity. At the La Jolla, California-based company, Chris assisted with challenging issues across the company’s full range of legal matters. He also clerked for Judge Jeremy Fogel of the United States District Court of Northern California, assisting on several high-stakes technology patent litigation matters.
Latham & Watkins
Christopher Healey
Partner
Davis Polk & Wardwell LLP
Christopher Henry
Associate
DLA Piper LLP (US)
Christopher Hogan
Managing partner
Hogan Thompson Schuelke LLP
Christopher Holding
Partner
Goodwin
Christopher Houpt
Partner
Mayer Brown
Christopher J. Cummings
Click here for attorney bio.
Paul, Weiss, Rifkind, Wharton & Garrison LLP
Christopher J. Major
Commercial Litigation & Cross-Border Dispute Resolution
Meister Seelig & Schuster